New bone drug may reveal hidden fracture risks

This study looks at how teriparatide, a drug that builds new bone, changes bone structure in 60 postmenopausal women with severe osteoporosis over two years. Researchers want to see if the drug affects bone thickness differently at the wrist versus the ankle, which could help predict fracture risk better than standard bone density scans. Participants must have had a fracture or be at high risk, and those with certain bone diseases or kidney problems cannot join.